Przejdź do zawartości
Merck

[Short-course chemotherapy of tuberculosis with pyrazinamide].

Nihon rinsho. Japanese journal of clinical medicine (1999-01-12)
S Asai, Y Futsuki, S Tomari, J Araki
ABSTRAKT

A 6-month regimen consisting of isoniazid (INH. 0.3-0.5 g).rifampicin (RFP. 0.3-0.45 g).pyrazinamide (PZA. 1.2-2.0 g) and streptomycin (SM. 0.75 g) or ethambutol (EB. 0.75-1.0 g) given for 2 month followed by isoniazid and rifampicin for 4 month is the preferred treatment for patients with fully susceptible organism, who adhere to treatment. Consideration should be given to treating all patients with directly observed treatment.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Pyrazinecarboxamide
Pyrazinamide, European Pharmacopoeia (EP) Reference Standard